Neuropathic pain practice review figure descriptions

This bar graph shows the number of unique patients who had a prescription for amitriptyline or pregabalin dispensed for them. Number of unique patients is shown on the y-axis, and ranges from 0 to 50, increasing in 10 unit increments. The financial years 2013–14, 2014–15, 2015–16 and 2016–17 are shown on the x-axis.

Data for two bars are displayed in each financial year. The left bar represents number of unique patients who had a prescription for pregabalin dispensed and the right bar represents the number of unique patients who had a prescription for amitriptyline dispensed.

Beginning at the leftmost bar in the graph:

• The first and second bars represent data for the financial year 2013-14. In this financial year, this GP had 14 patients who used pregabalin and 17 patients who used amitriptyline.
  
• The third and fourth bars represent data for the financial year 2014-15. In this financial year, this GP had 21 patients who used pregabalin and 16 patients who used amitriptyline.
  
• The fifth and sixth bars represent data for the financial year 2015-16. In this financial year, this GP had 29 patients who used pregabalin and 16 patients who used amitriptyline.
  
• The seventh and eighth bars represent data for the financial year 2016-17. In this financial year, this GP had 39 patients who used pregabalin and 10 patients who used amitriptyline.
  

Return to the Practice Review – Neuropathic pain: revisiting treatment options

This table shows the total number of patients who had amitriptyline dispensed in financial year 2016–17, as well as the number and percentage of patients who had only 10 mg strength tablets dispensed and the number and percentage of patients who had 10 mg and/or 25 mg strength tablets dispensed.

In financial year 2016-17, this GP had 10 patients using amitriptyline. Of these:

• 1 (10%) of patients were using only 10 mg strength tablets
  
• 2 (20%) of patients were using either 10 mg and/or 25 mg (but not 50 mg) strength tablets.
  

Return to the Practice Review – Neuropathic pain: revisiting treatment options 

This horizontal bar graph shows what percentage of the GP’s total number of patients using pregabalin,  were using either the 25 mg or 75 mg or 150 mg or 300 mg strength capsules. Strength of pregabalin tablet is shown on the y-axis. Four strengths are displayed: 25 mg is represented by the top bar, followed by 75 mg second from the top, 150 mg third from the top and 300 mg at the bottom. Percentage of patients is displayed on the x-axis, and ranges from 0 to 100% increasing in 20% increments. The total number of patients using pregabalin is also displayed on the x-axis label.

A note is provided at the bottom: Due to patients receiving multiple strengths of pregabalin on the same day, percentages may not total 100%. n = total number of patients. Data reflects prescriptions dispensed in financial year 2016–17.

In financial 2016-17, this GP had 39 patients using pregabalin. Of these:

• 36% were using 25 mg strength tablets
  
• 59% were using 75 mg strength tablets
  
• 5% were using 150 mg strength tablets
  
• 0% were using 300 mg strength tablets.
  

Return to the Practice Review – Neuropathic pain: revisiting treatment options 

This pie graph shows the number and percentage of patients using pregabalin who had 1–2, 3–6, 7–9 or ≥ 10 pregabalin prescriptions dispensed in 2016–17.

A reference to the expected prescription requirements of a patient using pregabalin treatment is provided. As each pack of pregabalin consists of 56 capsules, at the usual twice-daily dose of pregabalin, each pack of pregabalin should last 28 days. A patient would usually require 12 prescriptions per year.

In 2016-17, this GP had 39 patients using pregabalin treatment. Of these:

• 21 (54%) had 1-2 prescriptions dispensed
  
• 10 (26%) had 3-6 prescriptions dispensed
  
• 5 (13%) had 7-9 prescriptions dispensed
  
• 3 (8%) had ≥ 10 prescriptions dispensed.
  

Return to the Practice Review – Neuropathic pain: revisiting treatment options 

This graph shows the age profile of this GP's patients represented by a black line, as well as the shaded area between the 25th and 75th percentiles for the RA. Patient age group in years are displayed on the x-axis and is stratified into: 0–14, 15–29, 30–44, 45–59, 60–74, 75–89 and 90+. Number of patients is shown on the y-axis. The range shown is 0–800, increasing in 200 increments.

During the time period 1 July 2016 to 30 June 2017, this GP had:

• 249 patients aged 0-14 years. The 25th percentile in the RA is 125 patients and the 75th percentile in the RA is 514 patients
  
• 214 patients aged 15-29 years. The 25th percentile in the RA is 125 patients and the 75th percentile in the RA is 494 patients
  
• 235 patients aged 30-44 years. The 25th percentile in the RA is 158 patients and the 75th percentile in the RA is 556 patients
  
• 322 patients aged 45-59 years. The 25th percentile in the RA is 167 patients and the 75th percentile in the RA is 446 patients
  
• 304 of patients aged 60-74 years. The 25th percentile in the RA is 120 patients and the 75th percentile in the RA is 326 patients
  
• 156 number of patients aged 75-89 years. The 25th percentile in the RA is 41 patients and the 75th percentile in the RA is 148 patients
  
• 9 patients aged 90+. The 25th percentile in the RA is 3 patients and the 75th percentile in the RA is 14 patients.
  

Return to the Practice Review – Neuropathic pain: revisiting treatment options 

This table shows the total number of unique patients that the GP has seen between 1 April 2017 and 30 June 2017. The median for the RA is also provided. Number of patients is stratified into:

• patients who received a Medicare Category 1 benefit and
  
• patients who had a prescription written for them by this GP, who then had this prescription dispensed using a concession card (or safety net card).
  

Between 1 April 2017 and 30 June 2017, This GP had

• 777 patients who received a Medicare benefit category 1
  
• 315 patients who had a prescription written by this GP, and dispensed using a concession or safety net card.
  

Between 1 April 2017 and 30 June 2017 in this RA,

• The median number of patients who received a Medicare benefit category 1 is 624.
  
• The median number of patients who had a prescription dispensed using a concession or safety net card is 167.
  

Return to the Practice Review – Neuropathic pain: revisiting treatment options